On Tuesday, Mobileiron Inc (NASDAQ:MOBL)’s shares inclined 8.01% to $6.88.
MobileIron (MOBL), the leader in mobile enterprise security, recently declared it has been positioned by Gartner, Inc. in the Leaders quadrant of the “Magic Quadrant for Enterprise Mobility Administration Suites.”* This is the fifth successive year that MobileIron has been positioned in the Leaders Quadrant and the second successive year that MobileIron has been positioned furthest on the Completeness of Vision axis.
MobileIron, Inc. provides a purpose-built mobile IT platform that enables enterprises to secure and manage mobile applications, content, and devices while providing their employees with device choice, privacy, and a native user experience. The company’s MobileIron platform offers mobile device administration capabilities that enable IT to securely manage mobile devices across mobile operating systems and provide secure corporate email, automatic device configuration, and certificate-based security; and mobile application administration functionality, which assists IT manage the entire apps lifecycle, from making apps accessible in the enterprise app storefront, securing applications on the device, enforcing user authentication, isolating them from personal apps, and retiring them as necessary. Its MobileIron platform also provides mobile content administration that enable IT to provide secure mobile access to enterprise documents residing in SharePoint, file shares, and other enterprise and cloud content repositories, in addition to secures email attachments.
Advaxis, Inc. (NASDAQ:ADXS)’s shares dropped -9.99% to $22.07.
Advaxis, Inc. (ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, declared the company has presented a Special Protocol Assessment (SPA) request to the U.S. Food and Drug Administration (FDA) to initiate detailed design talk aboutions for a Phase 3 clinical study of ADXS-HPV for the treatment of high-risk, locally advanced cervical cancer (HRLACC). The Phase 3 trial is planned to be conducted in partnershipwith the Gynecologic Oncology Group (GOG) Foundation, Inc. and to be led by principal investigator Thomas Herzog, M.D., Professor of Obstetrics & Gynecology and Clinical Director at the University of Cincinnati Cancer Institute, Cincinnati, Ohio.
The SPA request comprises specific questions from Advaxis to facilitate a meaningful dialog with the FDA on the projected study design. Following receipt, the FDA will determine the appropriateness of the SPA request and may take up to 45 calendar days to provide comments to Advaxis. The nature and extent of comments received will determine the need for additional rounds of review and/or a formal meeting. The FDA’s assessment of the SPA request, and all related valuable feedback, will aid to inform the development of ADXS-HPV in locally advanced cervical cancer.
Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. The Lm-LLO immunotherapy platform technology stimulates the immune system to induce antigen-specific anti-tumor immune responses involving innate and adaptive arms of the immune system by inhibiting the T-cells, tregs, and myeloid-derived suppressor cells, and MDSC to promote immunologic tolerance of cancer cells in the tumor. Its lead product ADXS-HPV, an Lm-LLO immunotherapy product candidate used for the treatment of human papilloma virus (HPV) associated cancers, accomplished its Phase II study.
At the end of Tuesday’s trade, Qlik Technologies Inc (NASDAQ:QLIK)‘s shares surged 1.78% to $36.61.
Qlik Technologies Inc (QLIK) has selected QlikView® to drive raised visibility across its supply chain.
Nature’s Pride specializes in importing, exporting, ripening, packaging, and distributing exotic fruit and vegetables. To ensure each piece of produce is delivered at the peak level of freshness it is imperative the organization can track the supply chain from grower to consumer. Prior to Qlik, the organization struggled to manage its growing amounts of data, often stored on disparate systems, and had difficulties presenting it in an understandable way.
To overcome these issues, Nature’s Pride worked with Qlik partner UNIT4 for the full implementation of QlikView. With the deployment, Nature’s Pride was right away able to streamline its processes to drive efficiency and reduce costs in the supply chain. Employees could more easily access the data they needed with self-service analytics and were able to respond more nimbly with visual insights at the point of decision.
Qlik Technologies Inc. provides user-driven business intelligence solutions that enable customers to make business decisions. The company develops, commercializes, and implements software products and related services. It offers QlikView, which enables business users to explore data; ask and answer their own stream of questions; and follow their own path to insight on their own, or collaborate across teams and organizations.
Prudential Financial Inc (NYSE:PRU), ended its Tuesday’s trading session with 1.30% gain, and closed at $89.73.
Policymakers and investors need to work together to rectify an imbalance in global capital flows, according to a whitepaper issued by Prudential Investment Administration, the $962 billion asset administration business of Prudential Financial (PRU), and Knowledge@Wharton, the online research and business analysis journal of the Wharton School of the University of Pennsylvania.
The whitepaper entitled The Great Mismatch: Addressing Barriers to Global Capital Flows explores issues that hinder cross-border capital flows and offers recommendations for a new planned mindset and global framework. In developed markets, investors are sitting on under-invested capital which provides lackluster returns, while in emerging markets, public and private needs for investment go unmet.
The paper, researched and written with close cooperation of investment professionals from several Prudential Investment Administration businesses and Wharton’s scholars, lays out current barriers to efficient capital flows. Topics explored comprise the role of government, foundations of financial systems, and investors and their incentives.
Prudential Financial, Inc. provides insurance, investment administration, and other financial products and services to individual and institutional customers in the United States and internationally.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
